Safety, Tolerability and Pharmacokinetic Study of MRG-201 in Healthy Volunteers
Clinical trial NCT02603224 · COMPLETED
Trial details
- NCT number
- NCT02603224
- Sponsor
- miRagen Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2017-04-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.